Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Adial Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Adial Pharmaceuticals's enterprise value was -$19.21M on Oct 19, 2026, against $1.61M a year earlier. Over the last 5 years it ranged from -$19.21M to $49.67M, with a median of $1.20M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | -$19.21M | -3111.7% |
| 2025 | Dec 31, 2025 | $637.71K | -49.6% |
| 2024 | Dec 31, 2024 | $1.27M | -35.1% |
| 2023 | Dec 29, 2023 | $1.95M | +1156.5% |
| 2022 | Dec 30, 2022 | $155.16K | -99.7% |
| 2021 | Dec 31, 2021 | $48.03M | +185.8% |
| 2020 | Dec 31, 2020 | $16.81M | +3.2% |
| 2019 | Dec 31, 2019 | $16.28M | -43.4% |
| 2018 | Dec 31, 2018 | $28.75M | – |